Scientific Programme

Schütz W. - Rector of the Medical University of Vienna

Zielinski C. - Coordinator of the CCC - Comprehensive Cancer Center

Krepler R. - Director of the Vienna General Hospital

Moderation: Jakesz R. (A)
Chairs: Korcek J. (SK), Wrba F. (A)

Teleky B. (A)
Evolution and revolution in colorectal cancer

Andrea Maier (A)
EUS and MRI in the diagnosis of rectal cancer

Mariana Berho (US)
The role of molecular markers in the treatment of colorectal cancer

Iris Nagtegaal (NL)
Rectal cancer: what to expect from your pathologist?

Coffee break & exhibition

Moderation: Lechner P. (A)
Chairs: Trauner M. (A), Glaser K. (A)

Marshall J. (US)
Lessions learned from the successes in colon cancer

Moran B. (GB)
Concept of TME for rectal cancer

Rullier E. (F)
Laparoscopic TME for rectal cancer

Adam R. (F)
Onco-surgical management of colorectal liver metastases

Welcome Reception at the Upper Belvedere
(Guided Tour: Klimt, Schiele, Kokoschka)

Moderation: Schiedeck T. (D)
Chairs: Pfeifer J. (A), Pravosudov I. (RUS)

Wexner S. (US)
Current status of laparoscopy for colorectal carcinoma

Paty P. (US)
Anterior Resection Syndrome: new insights into an old problem

Herbst F. (A)
Experience with the ColonRing^TM in rectal reconstruction

Krivokapic Z. (SRB)
Multivisceral resection of rectal cancer

Jano Z. (H)
Results of mesh implantations at the time of Miles operation to prevent parastomal hernia

Coffee break & exhibition

Moderation: Adamina M. (CH)
Chairs: Shelygin Y. (RUS), Hauser H. (A)

Hohenberger W. (D)
Complete Mesocolic Excision – a way to standardize colon cancer surgery

Pahlman L. (S)
5 x 5 Gy in rectal cancer treatment, why not more often?

Romano G. (I)
Short term RT with long interval to surgery does impact on prognosis of rectal cancer

Rullier E. (F)
Local Excision vs TME for downstaged rectal cancer after radiochemotherapy: the GRECCAR 2 Trial

Discussion

Lunch & poster viewing & exhibition

Moderation: Steininger R. (A)
Chairs: Schindl M. (A), Längle F. (A)

Skricka T. (CZ)
Some fragments from the history of rectal cancer treatment

Gnant M. (A)
Success and challenges of an academic research network in Austria – the ABCSG story

Anjali Patil (IND)
New insights in pathogenesis management of metastatic liver disease of colorectal origin

Grünberger T. (A)
Defining resectability and the value of targeted agents in the neoadjuvant treatment of colorectal liver metastases

Silberhumer G. (A), Fong Y. (US)
Simultaneous resection of liver metastases in rectal cancer

Discussion

Coffee break & exhibition

Moderation: Pötter R. (A)
Chairs: Karaitianos I. (GR), Szczepkowski M. (PL)

Engel A. (NL)
The hostile pelvis

Valentini V. (I)
When the radiation oncologist can help the surgeons in rectal cancer management

Omejc M. (SLO)
Neoadjuvant treatment and perioperative outcome in rectal cancer

Mammadli Z. (RUS)
Neoadjuvant thermoradiochemotherapy of rectal cancer – 5-years results

Kartheuser A. (B)
TEM (Buess) for small rectal cancer treatment

Discussion

Coffee break & exhibition

Gala Dinner at the Vienna City Hall
(by invitation of the Major of Vienna)

Moderation: Ludwig H. (A)
Chairs: Gabriela Kornek (A), Damjanovich L. (H)

Milicevic M. (SRB)
Repeated operation for CRC liver metastases

Hoch J. (CZ)
Survival and quality of care for colorectal cancer – a 30 years experience of data collection in Czech Republic

Punt C. (NL)
The optimal use of targeted agents in metastatic colorectal cancer

Dziki A. (PL)
Lymph nodes as predictors of the outcome in rectal cancer

Discussion

Coffee break & exhibition

Moderation: Zielinski C. (A)
Chairs: Thaler J. (A), Nagy A. (H)

Wexner S. (US)
Methods of reconstruction after total mesorectal excision

Van Cutsem E. (B)
Towards personalized therapy for metastatic colorectal cancer

Paty P. (US)
Patterns of recurrence for resectable rectal cancer

Scheithauer W. (A)
Adjuvant therapy for colon cancer in 2011

Discussion